Results 111 to 120 of about 29,562 (196)
Transient hemodynamic dysfunction after myocardial revascularization
L. Czer+7 more
openalex +1 more source
Novel three‐dimensional ECG algorithm for reliable screening for cardiac amyloidosis
The present manuscript describes the derivation and validation of an algorithm for screening of cardiac amyloidosis using 3‐dimensional ECG. The algorithm is based on a ECG vector loop, acquired over the duration of 15 seconds using 4 electrodes. With this easy to perform method, we describe a high diagnostic accuracy for the detection of cardiac ...
Amir A. Mahabadi+8 more
wiley +1 more source
Among 668 with cardiogenic shock included in the multicentre prospective Altshock‐2 registry, 299 patients (44.8%) received pre‐admission beta‐blocker therapy. Previous beta‐blocker therapy influenced the early hemodynamic response to vasoactive drugs, but it was not associated with in‐hospital mortality.
Matteo Pagnesi+21 more
wiley +1 more source
Role of revascularization to treat chronic nonhealing fractures in ischemic limbs
David M. Deitz+3 more
openalex +1 more source
Short report: Hospitalization for new‐onset heart failure in survivors of hospitalized COVID‐19
Abstract Aims Previous studies have reported an incidence of new‐onset heart failure (HF) among COVID‐19 survivors ranging from 0.7 to 8.5 per 100 person‐years, but they relied on administrative data for outcome ascertainment. Given the public health implications, a more accurate characterization of the HF burden post‐COVID‐19 is important. Methods and
Vicente Corrales‐Medina+6 more
wiley +1 more source
Noncardioplegic myocardial preservation for coronary revascularization
Cary W. Akins
openalex +1 more source
Determinants of I O-year Survival after Primary Myocardial Revascularization
Delos M. Cosgrove+8 more
openalex +2 more sources
INTRAVENOUS LABETALOL FOR BLOOD PRESSURE REDUCTION FOLLOWING MYOCARDIAL REVASCULARIZATION [PDF]
Donald S. Prough+3 more
openalex +1 more source
Finerenone and glycaemic status in patients with heart failure with mildly reduced/preserved ejection fraction. CI, confidence interval; CV, cardiovascular; HF, heart failure; HR, hazard ratio; RR, rate ratio. Abstract Aims The efficacy and safety of the non‐steroidal mineralocorticoid receptor antagonist, finerenone, have not been examined in patients
Jawad H. Butt+18 more
wiley +1 more source